T. Rowe Price Associates’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Hold |
24,987
| – | – | ﹤0.01% | 2493 |
|
|
2025
Q1 | $373K | Buy |
24,987
+1,268
| +5% | +$18.9K | ﹤0.01% | 2372 |
|
|
2024
Q4 | $431K | Buy |
23,719
+6,214
| +35% | +$113K | ﹤0.01% | 2337 |
|
|
2024
Q3 | $236K | Buy |
17,505
+226
| +1% | +$3.05K | ﹤0.01% | 2583 |
|
|
2024
Q2 | $240K | Buy |
17,279
+640
| +4% | +$8.89K | ﹤0.01% | 2519 |
|
|
2024
Q1 | $312K | Buy |
16,639
+1,450
| +10% | +$27.2K | ﹤0.01% | 2415 |
|
|
2023
Q4 | $344K | Buy |
15,189
+1,970
| +15% | +$44.6K | ﹤0.01% | 2336 |
|
|
2023
Q3 | $328K | Buy |
13,219
+453
| +4% | +$11.2K | ﹤0.01% | 2292 |
|
|
2023
Q2 | $359K | Buy |
+12,766
| New | +$359K | ﹤0.01% | 2280 |
|
|
2021
Q3 | – | Sell |
-253,026
| Closed | -$4.18M | – | 2938 |
|
|
2021
Q2 | $4.18M | Sell |
253,026
-2,124,186
| -89% | -$35.1M | ﹤0.01% | 1533 |
|
|
2021
Q1 | $29.7M | Sell |
2,377,212
-80,377
| -3% | -$1M | ﹤0.01% | 1172 |
|
|
2020
Q4 | $21.8M | Sell |
2,457,589
-14,250
| -0.6% | -$126K | ﹤0.01% | 1206 |
|
|
2020
Q3 | $16M | Buy |
2,471,839
+6,000
| +0.2% | +$38.9K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $15.2M | Buy |
2,465,839
+16,405
| +0.7% | +$101K | ﹤0.01% | 1212 |
|
|
2020
Q1 | $16.5M | Sell |
2,449,434
-13,670
| -0.6% | -$92.1K | ﹤0.01% | 1123 |
|
|
2019
Q4 | $28.6M | Buy |
2,463,104
+7,117
| +0.3% | +$82.7K | ﹤0.01% | 1077 |
|
|
2019
Q3 | $25.3M | Buy |
2,455,987
+11,956
| +0.5% | +$123K | ﹤0.01% | 1084 |
|
|
2019
Q2 | $22.9M | Sell |
2,444,031
-200
| -0% | -$1.88K | ﹤0.01% | 1139 |
|
|
2019
Q1 | $17.2M | Buy |
2,444,231
+19,400
| +0.8% | +$136K | ﹤0.01% | 1220 |
|
|
2018
Q4 | $17.8M | Buy |
2,424,831
+13,959
| +0.6% | +$102K | ﹤0.01% | 1186 |
|
|
2018
Q3 | $21M | Buy |
2,410,872
+21,982
| +0.9% | +$192K | ﹤0.01% | 1217 |
|
|
2018
Q2 | $26.9M | Buy |
2,388,890
+11,939
| +0.5% | +$134K | ﹤0.01% | 1099 |
|
|
2018
Q1 | $26.4M | Buy |
2,376,951
+83,121
| +4% | +$923K | ﹤0.01% | 1087 |
|
|
2017
Q4 | $29.3M | Buy |
2,293,830
+535,130
| +30% | +$6.83M | ﹤0.01% | 1052 |
|
|
2017
Q3 | $25M | Sell |
1,758,700
-3,430
| -0.2% | -$48.8K | ﹤0.01% | 1096 |
|
|
2017
Q2 | $22.7M | Buy |
1,762,130
+3,730
| +0.2% | +$48.2K | ﹤0.01% | 1124 |
|
|
2017
Q1 | $25.3M | Sell |
1,758,400
-36,150
| -2% | -$519K | ﹤0.01% | 1062 |
|
|
2016
Q4 | $28M | Buy |
1,794,550
+11,900
| +0.7% | +$186K | 0.01% | 1015 |
|
|
2016
Q3 | $21M | Buy |
1,782,650
+612,440
| +52% | +$7.21M | ﹤0.01% | 1109 |
|
|
2016
Q2 | $16.3M | Buy |
1,170,210
+995,820
| +571% | +$13.9M | ﹤0.01% | 1160 |
|
|
2016
Q1 | $2.03M | Buy |
+174,390
| New | +$2.03M | ﹤0.01% | 1517 |
|
|
2015
Q1 | – | Sell |
-254,300
| Closed | -$3.17M | – | 2544 |
|
|
2014
Q4 | $3.17M | Sell |
254,300
-50,000
| -16% | -$624K | ﹤0.01% | 1522 |
|
|
2014
Q3 | $2.83M | Hold |
304,300
| – | – | ﹤0.01% | 1534 |
|
|
2014
Q2 | $1.98M | Buy |
+304,300
| New | +$1.98M | ﹤0.01% | 1575 |
|